Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease.

Li R, Guo G, Cao Y, Wang Y, Liu F, Zhang X.

Pharmacology. 2013;92(1-2):26-31. doi: 10.1159/000348575. Epub 2013 Jul 18.

PMID:
23867551
2.

Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation.

Cui Y, Wang Q, Li X, Zhang X.

Redox Biol. 2013 Aug 24;1:433-40. doi: 10.1016/j.redox.2013.08.003. eCollection 2013.

3.
4.

Endoplasmic reticulum stress due to altered cellular redox status positively regulates murine hepatic CYP2A5 expression.

Gilmore WJ, Kirby GM.

J Pharmacol Exp Ther. 2004 Feb;308(2):600-8. Epub 2003 Nov 10.

5.

Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.

Gilmore WJ, Hartmann G, Piquette-Miller M, Marriott J, Kirby GM.

Toxicology. 2003 Mar 3;184(2-3):211-26.

PMID:
12499123
6.

Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress.

Nichols KD, Kirby GM.

Biochem Pharmacol. 2008 Mar 1;75(5):1230-9. Epub 2007 Nov 7.

PMID:
18068688
7.

Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions.

Wastl UM, Rossmanith W, Lang MA, Camus-Randon AM, Grasl-Kraupp B, Bursch W, Schulte-Hermann R.

Mol Carcinog. 1998 Aug;22(4):229-34.

PMID:
9726815
8.

Cytochrome P450 2A5 and bilirubin: mechanisms of gene regulation and cytoprotection.

Kim SD, Antenos M, Squires EJ, Kirby GM.

Toxicol Appl Pharmacol. 2013 Jul 15;270(2):129-38. doi: 10.1016/j.taap.2013.04.013. Epub 2013 Apr 26.

PMID:
23628428
9.
10.

Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa.

Su T, He W, Gu J, Lipinskas TW, Ding X.

Drug Metab Dispos. 1998 Aug;26(8):822-4.

11.

Effects of Fatty Acids on CYP2A5 and Nrf2 Expression in Mouse Primary Hepatocytes.

Cui Y, Wang Q, Yi X, Zhang X.

Biochem Genet. 2016 Feb;54(1):29-40. doi: 10.1007/s10528-015-9697-6. Epub 2015 Sep 30.

PMID:
26423681
12.

Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver.

Salonpää P, Krause K, Pelkonen O, Raunio H.

Naunyn Schmiedebergs Arch Pharmacol. 1995 Apr;351(4):446-52.

PMID:
7543189
14.

Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5.

Abu-Bakar A, Moore MR, Lang MA.

Biochem Pharmacol. 2005 Nov 15;70(10):1527-35. Epub 2005 Sep 23.

PMID:
16183037
15.

Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes.

Kojo A, Viitala P, Pasanen M, Pelkonen O, Raunio H, Juvonen R.

Arch Toxicol. 1998 May;72(6):336-41.

PMID:
9657280
16.
17.

[Induction of cytochrome P450 2A5 in transplanted mouse hepatoma].

Kulikova LN.

Biomed Khim. 2004 May-Jun;50(3):260-8. Russian.

PMID:
15354536
18.
19.

Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver.

Abu-Bakar A, Hakkola J, Juvonen R, Rahnasto-Rilla M, Raunio H, Lang MA.

Curr Drug Metab. 2013 Jan;14(1):137-50. Review.

PMID:
22497566
20.

Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis.

Chen X, Ward SC, Cederbaum AI, Xiong H, Lu Y.

Toxicology. 2017 Mar 15;379:12-21. doi: 10.1016/j.tox.2017.01.016. Epub 2017 Jan 25.

PMID:
28131861

Supplemental Content

Support Center